|
SUNDAY,
SEPTEMBER 29, 2002 |
MONDAY,
SEPTEMBER 30, 2002 |
TUESDAY,
OCTOBER 1, 2002 |
WEDNESDAY,
OCTOBER 2, 2002 |
THURSDAY,
OCTOBER 3, 2002 |
| Orals |
Orals
|
Posters |
Orals
|
Posters |
Orals
|
Posters
|
Orals
|
Posters
|
| TUESDAY, OCTOBER 1, 2002 |
| POSTER SESSION: CNS IN APS |
| 1 |
ISCHEMIC
STROKE IN A BOY WITH PRIMARY APS
A. Attilakos, S. Fessatou, H. Tsapra, E. Katsarou,
V. Tzavara, C. Dracou, Greece |
| 2 |
INDUCTION
OF EXPERIMENTAL APS WITH CNS INVOLVEMENT IN 5 DIFFERENT MOUSE STRAINS
A. Katzav, C.G. Pick, A.D. Korczyn, Y. Litvinjuk, S.
Shrot, M. Blank, Y. Shoenfeld,
P. Sirota, J. Chapman, Israel |
| 3 |
APS
EXACERBATES COGNITIVE IMPAIRMENT IN AN APP MOUSE MODEL OF ALZHEIMER'S DISEASE
A. Katzav, C.G. Pick, A.D. Korczyn, M. Blank, Y. Shoenfeld,
J. Chapman, Israel |
| 4 |
NEUROLOGICAL
MANIFESTATIONS IN PATIENTS WITH aPLS
J. Szilasiova, E. Klimova, Z. Macejova, Slovak Republic |
| 5 |
ANTIPHOSPHOLIPID
ANTIBODIES IN PATIENTS WITH NEUROPSYCHIATRIC SYSTEMIC LUPUS
L. Stojanovich, I. Elezovich, R. Stojanovich, V. Mirchetich,
V. Kostich, Yugoslavia |
| 6 |
FACTOR
VIII (FVIII) ACTIVIY IN PATIENTS WITH SNEDDON’S SYNDROME (SS)
L. Kalashnikova, A. Berkovski, L. Dobrynina, E. Sergeeva,
A. Kozlov, E. Alexandrova, E. Nassonov, Russia |
| 7 |
STROKE
IN DOWN SYNDROME: AN ASSOCIATION WITH ANTIPHOSPHOLIPID ANTIBODIES
P.A. Gatenby, R.R. Tuck, C.J. Andrews, R. O'Neil, Australia |
| 8 |
aCL
IN ACUTE STROKE SUBTYPES
K.N. Vemmos, P.G. Konstantopoulou, G.K. Tsivgoulis,
C.D. Evangelopoulos,
D.A. Sotos, A.J. Leventakos, M. Dalesios, Greece |
| 9 |
POSITRON
EMISSION TOMOGRAPHY ABNORMALITIES IN LUPUS PATIENTS WITH COGNITIVE DYSFUNCTION
AND aPL
D. Hermosillo-Romo, S.L. Holliday, J. Xiong, J. Lancaster,
R.L. Brey, USA |
| 10 |
ANTI-ICAM
AB PARTIALLY IMPROVE NEUROLOGIC DYSFUNCTION IN MICE WITH EXPERIMENTAL APS
L. Ziporen, J. Chapman, L. Rauova, R. Brey, Y. Shoenfeld,
Israel |
| 11 |
CEREBRAL
MAGNETIC RESONANCE IMAGING (mRI) IN PATIENTS WITH SLE AND APS
J. I. Bernardino, M. Mora, S. Novo, P. Garcia Raya,
L. Diez Porres, A. Robles,
F. Garcia Iglesias, P. Lavilla, N. Sastre, A. Gil Aguado,
Spain |
| 12 |
SILENT
ISCHEMIA IN SLE AND APS: CLINICAL AND MORPHOLOGICAL FEATURES IN CEREBRAL
MAGNETIC RESONANCE IMAGING
J I. Bernardino, M. Mora, S. Novo, P. Garcia Raya,
L. Diez Porres, A. Robles, F. Garcia Iglesias, P. Lavilla,
N. Sastre, A. Gil Aguado, Spain |
| 13 |
CEREBRAL
VENOUS THROMBOSIS AND APS - REPORT OF A CASE
A.C.S. Grilo, F.C. Soromenho, M.V. Riscado, Portugal |
| 14 |
ACTIVATION
OF ERK IN BRAIN ENDOTHELIAL CELLS BY THROMBIN AND aPLS AND ITS MODULATION
BY THE RAS INHIBITOR, FARNESYLTHIOSALICILATE
R. Aronovich, D. Gurwitz, Y. Kloog, J. Chapman, Israel |
| 15 |
STROKES
SECONDARY TO APS IN SLE
M.R. Sivakumar, India |
| 16 |
COGNITIVE
FUNCTIONING IN SECONDARY APS: AGE EFFECTS AND THE ROLE OF ANTI-B2GP2
S.L. Holliday, D. Hermosillo Romo, A. Saklad, R.L. Brey,
USA |
| |
| POSTER SESSION: COAGULATION
IN APS |
| 17 |
THROMBOPHILIA
AS A PREDICTOR OF RECURRENT MISCARRIAGE
M.O. Sugiura, Y. Iinuma, K. Katano, Y. Ozaki, K. Suzumori,
Japan |
| 18 |
HETEROGENEITIES
OF LUPUS ANTICOAGULANT ANTIBODIES (LA): DIFFERENT LIGAND-SPECIFICITIES DETERMINE
A CLINICAL FEATURES OF APS
M. Yamazaki, M. Kaneda, T. Yoshida, Y. Ontachi, T.
Mizutani, T. Ito, H. Asakura,
S. Nakao, Japan |
| 19 |
FACTOR
V LEIDEN, FII G20210A AND MTHFR C677T AND THE RISK OF VENOUS THROMBOEMBOLISM,
ARTERIAL THROMBOSIS AND RECURRENT MISCARRIAGE IN APS
F. Pieroni, M.V.C. Freitas, M.A. Zago, A.G. Araujo, M.H. Tavella,
P. Louzada-Jr,
R.F. Franco, Brazil |
| 20 |
INSENSITIVITY
OF THROMBIN GENERATION TO ACTIVATED PROTEIN C IN SELECTED PATIENTS WITH
aPLS
V. Regnault, S. Beguin, E. De Maistre, D. Wahl, H.C.
Hemker, T. Lecompte, France |
| 21 |
CLINICAL
SIGNIFICANCE OF ACTIVATED FACTOR XIII IN PRIMARY APS
P.R.J. Ames, A. Margarita, L. Iannaccone, V. Brancaccio,
UK, Italy |
| 22 |
PROTEIN
C INHIBITOR, ISOLATED TOGETHER WITH B2GPI, REACTED WITH APS SERA
B. Bozic, S. Cucnik, I. Krizaj, T. Kveder, Slovenia |
| 23 |
COMPARISON
OF THREE DIFFERENT VACUTAINER COLLECTION SYSTEMS FOR THE DETERMINATION OF
THE DILUTE RUSSELLS VIPER VENOM TIME
W.F. Warner, A. Bowyer, M. Makris, M. Akil, D. Pastorelli,
C. Brookfield, E. Hampton, S. Kitchen, UK |
| 24 |
THROMBOSIS
IN LUPUS PATIENTS. ANTIPHOSPHOLIPID ANTIBODIES, ANTI-INHIBITOR PROTEIN ANTIBODIES
OF BLOOD COAGULATION AND NON INMUNE RISK FACTORS STUDY
J. Ordi-Ros, M. Mauri, J. Paredes, E. Balada, J. Villarreal,
M. Vilardell, Spain |
| |
| POSTER SESSION: APS AND
OTHER DISEASES |
| 25 |
THE
BENEFICIAL EFFECT OF ANTIMALARIALS IN THE TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC
PURPURA
E. Toubi, A. Kessel, D. Atias, B. Brener, Israel |
| 26 |
PERSISTENTLY
HIGH IGG aCL RELATED TO THROMBOTIC FEATURES IN BEHCET'S DISEASE, TAKAYASU'S
ARTERITIS AND WEGENER'S GRANULOMATOSIS
R.A. Levy, M.N. Elisa, A. Bozza, B.E.G. Bica, R.A.
Asherson, Brazil, South Africa |
| 27 |
COFACTOR
INDEPENDENT ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH LYMPHOPROLIFERATIVE
DISEASES
S.B. Andrejevic, M.N. Bukilica, B.M. Bonaci-Nikolic,
Yugoslavia |
| 28 |
HIGH
INCIDENCE OF ARTERIAL THROMBOSIS DUE TO aPLS IN PATIENTS WITH EVANS' SYNDROME;
SIGNIFICANCE OF DETECTING LUPUS ANTICOAGULANT AS A PREDICTOR
M. Yamazaki, T. Yoshida, M. Kaneda, Y. Ontachi, T.
Mizutani, T. Ito, H. Asakura,
S. Nakao, Japan |
| 29 |
aPLS
AND RHEUMATOID ARTHRITIS: PREVALENCE, CLINICAL SIGNIFICANCE IN A COHORT
OF 200 CONSECUTIVE PATIENTS
P. Sarzi-Puttini, E. Rossi, F. Atzeni, G. Santalena,
G. Randisi, M. Carrabba, Italy |
| 30 |
LUPUS
ANTICOAGULANT, aCL AND ANTI-B2GPI ANTIBODIES IN PATIENTS WITH THALASSEMIA
Z. Mondher, C.M. Heithem, L. Lilia, A.M. Slim, S. Maryam,
M.F. Ben Dridi, M. Sondes, Tunisia |
| 31 |
ADDISON'S
DISEASE AS THE FIRST MANIFESTATION OF THE PRIMARY ANTIPHOSPHOLIPID ANTIBODY
SYNDROME
R. Foti, R. Leonardi, S. Fagone, M. Di Gangi, Italy |
SUNDAY,
SEPTEMBER 29, 2002 |
MONDAY,
SEPTEMBER 30, 2002 |
TUESDAY,
OCTOBER 1, 2002 |
WEDNESDAY,
OCTOBER 2, 2002 |
THURSDAY,
OCTOBER 3, 2002 |
| Orals |
Orals
|
Posters |
Orals
|
Posters |
Orals
|
Posters
|
Orals
|
Posters
|
|
|
